The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation

Abroad (travel likely)RecruitingPHASE2

Conditions

Type 1 Diabetes · Chronic Inflammation · Insulin Sensitivity

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup, Capital Region 2900, Gentofte Municipality, Denmark
Contact: Study coordinator (Asger B Lund, MD, PhD) · asger.lund.01@regionh.dk · 004538674266
Contact: Study coordinator (Aske N Høck, MD) · aske.nicolai.hoeck@regionh.dk · 004561275585

Study leads

Asger B Lund, MD, PhD
Principal Investigator
Center for Clinical Metabolic Research, Gentofte Hospital, Denmark

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Type 1 Diabetes Mellitus · T1D · T1DM

Abroad (travel likely)RecruitingPHASE1, PHASE2

Tucson, United States · Tucson, United States

Denosumab for Type 1 Diabetes

Type 1 Diabetes

Abroad (travel likely)RecruitingPHASE1, PHASE2

Birmingham, United States · Duarte, United States

GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab

Type 1 Diabetes

Abroad (travel likely)RecruitingEARLY_PHASE1

Nashville, United States

An Adaptive Design Study of MTX228

Type 1 Diabetes Mellitus

Abroad (travel likely)RecruitingPHASE2

Edmonton, Canada